Leonardo Palumbo, Médecins Sans Frontières (MSF), reflects on the new WHO guidelines for MDR-TB. Recent treatment regimens for drug-resistant tuberculosis (DR-TB) have resulted in patients enduring a gruelling two-year treatment journey, which necessitates taking up to
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.